Annual CFI:
-$116.84M+$219.51M(+65.26%)Summary
- As of today, ALNY annual cash from investing is -$116.84 million, with the most recent change of +$219.51 million (+65.26%) on December 31, 2024.
- During the last 3 years, ALNY annual cash from investing has risen by +$156.46 million (+57.25%).
- ALNY annual cash from investing is now -142.81% below its all-time high of $272.94 million, reached on December 31, 2018.
Performance
ALNY Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFI:
-$141.38M-$255.15M(-224.27%)Summary
- As of today, ALNY quarterly cash from investing is -$141.38 million, with the most recent change of -$255.15 million (-224.27%) on June 30, 2025.
- Over the past year, ALNY quarterly cash from investing has dropped by -$175.32 million (-516.56%).
- ALNY quarterly cash from investing is now -145.04% below its all-time high of $313.89 million, reached on September 30, 2022.
Performance
ALNY Quarterly Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$110.77M-$175.32M(-271.61%)Summary
- As of today, ALNY TTM cash from investing is -$110.77 million, with the most recent change of -$175.32 million (-271.61%) on June 30, 2025.
- Over the past year, ALNY TTM cash from investing has increased by +$174.33 million (+61.15%).
- ALNY TTM cash from investing is now -121.70% below its all-time high of $510.41 million, reached on March 31, 2019.
Performance
ALNY TTM Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
ALNY Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +65.3% | -516.6% | +61.1% |
| 3Y3 Years | +57.3% | -199.0% | +78.1% |
| 5Y5 Years | +72.0% | +68.0% | +80.2% |
ALNY Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -169.0% | +65.3% | -145.0% | +41.3% | -146.1% | +67.1% |
| 5Y | 5-Year | -169.0% | +73.2% | -145.0% | +65.8% | -146.1% | +80.2% |
| All-Time | All-Time | -142.8% | +78.7% | -145.0% | +68.0% | -121.7% | +80.2% |
ALNY Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$141.38M(-224.3%) | -$110.77M(-271.6%) |
| Mar 2025 | - | $113.77M(+315.0%) | $64.55M(+155.2%) |
| Dec 2024 | -$116.84M(+65.3%) | -$52.91M(-74.9%) | -$116.84M(+61.6%) |
| Sep 2024 | - | -$30.25M(-189.1%) | -$304.59M(-6.8%) |
| Jun 2024 | - | $33.94M(+150.2%) | -$285.10M(+13.0%) |
| Mar 2024 | - | -$67.62M(+71.9%) | -$327.75M(+2.6%) |
| Dec 2023 | -$336.35M(-298.6%) | -$240.66M(-2135.7%) | -$336.35M(-42.8%) |
| Sep 2023 | - | -$10.76M(-23.5%) | -$235.60M(-364.6%) |
| Jun 2023 | - | -$8.71M(+88.6%) | $89.05M(-63.0%) |
| Mar 2023 | - | -$76.22M(+45.5%) | $240.56M(+42.0%) |
| Dec 2022 | $169.35M(+162.0%) | -$139.91M(-144.6%) | $169.35M(+262.6%) |
| Sep 2022 | - | $313.89M(+119.8%) | -$104.14M(+79.4%) |
| Jun 2022 | - | $142.79M(+196.9%) | -$506.30M(-2.9%) |
| Mar 2022 | - | -$147.42M(+64.3%) | -$492.07M(-80.0%) |
| Dec 2021 | -$273.30M(+37.2%) | -$413.40M(-368.3%) | -$273.30M(-747.4%) |
| Sep 2021 | - | -$88.27M(-156.2%) | $42.22M(-64.9%) |
| Jun 2021 | - | $157.02M(+120.1%) | $120.40M(+125.2%) |
| Mar 2021 | - | $71.35M(+172.9%) | -$477.85M(-9.7%) |
| Dec 2020 | -$435.52M(-4.3%) | -$97.89M(-870.3%) | -$435.52M(+22.0%) |
| Sep 2020 | - | -$10.09M(+97.7%) | -$558.48M(-0.0%) |
| Jun 2020 | - | -$441.23M(-488.1%) | -$558.47M(-37.3%) |
| Mar 2020 | - | $113.69M(+151.5%) | -$406.64M(+2.6%) |
| Dec 2019 | -$417.68M(-253.0%) | -$220.85M(-2091.6%) | -$417.68M(-901.1%) |
| Sep 2019 | - | -$10.08M(+96.5%) | $52.14M(-67.1%) |
| Jun 2019 | - | -$289.40M(-381.9%) | $158.39M(-69.0%) |
| Mar 2019 | - | $102.65M(-58.8%) | $510.41M(+87.0%) |
| Dec 2018 | $272.94M(+194.0%) | $248.96M(+158.9%) | $272.94M(+299.8%) |
| Sep 2018 | - | $96.17M(+53.6%) | -$136.61M(+63.1%) |
| Jun 2018 | - | $62.62M(+146.4%) | -$369.96M(+26.0%) |
| Mar 2018 | - | -$134.81M(+16.0%) | -$500.25M(-72.3%) |
| Dec 2017 | -$290.36M(-303.6%) | -$160.59M(-17.1%) | -$290.36M(-888.2%) |
| Sep 2017 | - | -$137.18M(-102.7%) | -$29.38M(-138.5%) |
| Jun 2017 | - | -$67.67M(-190.1%) | $76.39M(-23.4%) |
| Mar 2017 | - | $75.08M(-25.2%) | $99.73M(-30.1%) |
| Dec 2016 | $142.59M(+144.4%) | $100.39M(+419.7%) | $142.59M(+18.4%) |
| Sep 2016 | - | -$31.41M(+29.2%) | $120.47M(-39.9%) |
| Jun 2016 | - | -$44.34M(-137.6%) | $200.55M(+45.4%) |
| Mar 2016 | - | $117.94M(+50.7%) | $137.95M(+142.9%) |
| Dec 2015 | -$321.32M(+41.5%) | $78.27M(+60.8%) | -$321.32M(+15.0%) |
| Sep 2015 | - | $48.67M(+145.5%) | -$378.16M(+2.8%) |
| Jun 2015 | - | -$106.94M(+68.7%) | -$388.92M(+23.8%) |
| Mar 2015 | - | -$341.33M(-1692.4%) | -$510.36M(+7.0%) |
| Dec 2014 | -$548.81M | $21.43M(-43.5%) | -$548.81M(-6.7%) |
| Sep 2014 | - | $37.91M(+116.6%) | -$514.20M(+7.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2014 | - | -$228.38M(+39.9%) | -$554.61M(-46.2%) |
| Mar 2014 | - | -$379.78M(-777.6%) | -$379.44M(-190.8%) |
| Dec 2013 | -$130.50M(-3968.0%) | $56.05M(+2338.3%) | -$130.50M(+8.8%) |
| Sep 2013 | - | -$2.50M(+95.3%) | -$143.04M(-16.6%) |
| Jun 2013 | - | -$53.21M(+59.3%) | -$122.68M(-98.3%) |
| Mar 2013 | - | -$130.84M(-400.7%) | -$61.87M(-1933.8%) |
| Dec 2012 | $3.37M(-95.9%) | $43.51M(+143.7%) | $3.37M(+117.4%) |
| Sep 2012 | - | $17.85M(+134.9%) | -$19.36M(-1922.5%) |
| Jun 2012 | - | $7.60M(+111.6%) | -$957.00K(+83.8%) |
| Mar 2012 | - | -$65.59M(-415.6%) | -$5.92M(-107.2%) |
| Dec 2011 | $81.96M(+359.5%) | $20.78M(-42.7%) | $81.96M(-24.6%) |
| Sep 2011 | - | $36.25M(+1274.7%) | $108.75M(+40.9%) |
| Jun 2011 | - | $2.64M(-88.2%) | $77.19M(+62.2%) |
| Mar 2011 | - | $22.29M(-53.2%) | $47.59M(+166.8%) |
| Dec 2010 | $17.84M(+23.6%) | $47.58M(+915.8%) | $17.84M(-31.1%) |
| Sep 2010 | - | $4.68M(+117.4%) | $25.88M(+395.4%) |
| Jun 2010 | - | -$26.96M(-261.3%) | -$8.76M(+67.7%) |
| Mar 2010 | - | -$7.46M(-113.4%) | -$27.15M(-288.1%) |
| Dec 2009 | $14.43M(-19.5%) | $55.62M(+285.7%) | $14.43M(+138.2%) |
| Sep 2009 | - | -$29.95M(+34.0%) | -$37.79M(+14.7%) |
| Jun 2009 | - | -$45.36M(-232.9%) | -$44.28M(+8.1%) |
| Mar 2009 | - | $34.13M(+904.0%) | -$48.18M(-368.6%) |
| Dec 2008 | $17.94M(+106.5%) | $3.40M(+109.3%) | $17.94M(+124.5%) |
| Sep 2008 | - | -$36.45M(+26.0%) | -$73.15M(+63.9%) |
| Jun 2008 | - | -$49.26M(-149.1%) | -$202.59M(-59.1%) |
| Mar 2008 | - | $100.24M(+214.3%) | -$127.33M(+54.1%) |
| Dec 2007 | -$277.43M(-823.3%) | -$87.69M(+47.1%) | -$277.43M(-42.6%) |
| Sep 2007 | - | -$165.89M(-737.9%) | -$194.58M(-632.4%) |
| Jun 2007 | - | $26.00M(+152.2%) | -$26.57M(+60.5%) |
| Mar 2007 | - | -$49.85M(-930.2%) | -$67.19M(-123.6%) |
| Dec 2006 | -$30.05M(+25.7%) | -$4.84M(-328.4%) | -$30.05M(+58.5%) |
| Sep 2006 | - | $2.12M(+114.5%) | -$72.42M(-3.4%) |
| Jun 2006 | - | -$14.62M(-15.0%) | -$70.07M(-34.2%) |
| Mar 2006 | - | -$12.71M(+73.1%) | -$52.22M(-29.2%) |
| Dec 2005 | -$40.42M(-16.8%) | -$47.21M(-1155.3%) | -$40.42M(-624.0%) |
| Sep 2005 | - | $4.47M(+38.5%) | $7.71M(+166.0%) |
| Jun 2005 | - | $3.23M(+455.7%) | -$11.70M(+65.0%) |
| Mar 2005 | - | -$908.00K(-198.9%) | -$33.43M(+3.4%) |
| Dec 2004 | -$34.59M(-967.7%) | $918.00K(+106.1%) | -$34.59M(+2.6%) |
| Sep 2004 | - | -$14.94M(+19.3%) | -$35.51M(-72.6%) |
| Jun 2004 | - | -$18.51M(-793.1%) | -$20.58M(-893.1%) |
| Mar 2004 | - | -$2.07M | -$2.07M |
| Dec 2003 | -$3.24M(-476.5%) | - | - |
| Dec 2002 | -$562.00K | - | - |
FAQ
- What is Alnylam Pharmaceuticals, Inc. annual cash from investing?
- What is the all-time high annual cash from investing for Alnylam Pharmaceuticals, Inc.?
- What is Alnylam Pharmaceuticals, Inc. annual cash from investing year-on-year change?
- What is Alnylam Pharmaceuticals, Inc. quarterly cash from investing?
- What is the all-time high quarterly cash from investing for Alnylam Pharmaceuticals, Inc.?
- What is Alnylam Pharmaceuticals, Inc. quarterly cash from investing year-on-year change?
- What is Alnylam Pharmaceuticals, Inc. TTM cash from investing?
- What is the all-time high TTM cash from investing for Alnylam Pharmaceuticals, Inc.?
- What is Alnylam Pharmaceuticals, Inc. TTM cash from investing year-on-year change?
What is Alnylam Pharmaceuticals, Inc. annual cash from investing?
The current annual cash from investing of ALNY is -$116.84M
What is the all-time high annual cash from investing for Alnylam Pharmaceuticals, Inc.?
Alnylam Pharmaceuticals, Inc. all-time high annual cash from investing is $272.94M
What is Alnylam Pharmaceuticals, Inc. annual cash from investing year-on-year change?
Over the past year, ALNY annual cash from investing has changed by +$219.51M (+65.26%)
What is Alnylam Pharmaceuticals, Inc. quarterly cash from investing?
The current quarterly cash from investing of ALNY is -$141.38M
What is the all-time high quarterly cash from investing for Alnylam Pharmaceuticals, Inc.?
Alnylam Pharmaceuticals, Inc. all-time high quarterly cash from investing is $313.89M
What is Alnylam Pharmaceuticals, Inc. quarterly cash from investing year-on-year change?
Over the past year, ALNY quarterly cash from investing has changed by -$175.32M (-516.56%)
What is Alnylam Pharmaceuticals, Inc. TTM cash from investing?
The current TTM cash from investing of ALNY is -$110.77M
What is the all-time high TTM cash from investing for Alnylam Pharmaceuticals, Inc.?
Alnylam Pharmaceuticals, Inc. all-time high TTM cash from investing is $510.41M
What is Alnylam Pharmaceuticals, Inc. TTM cash from investing year-on-year change?
Over the past year, ALNY TTM cash from investing has changed by +$174.33M (+61.15%)